Syngene is thrilled to announce its participation in the upcoming Festival of Biologics, scheduled from 15-17 April 2024 in San Diego, California.
With over 30 years of industry experience, Syngene offers comprehensive biologics services covering mammalian and microbial systems. From drug discovery to development and manufacturing, Syngene provides integrated solutions tailored to clients’ needs.
Syngene’s state-of-the-art facilities boast approvals from regulatory bodies such as the US FDA, EMA, and MHRA, along with certifications in GLP, GMP and ISO standards. Recent expansions include a Single-Use Bioreactor (SUB) capacity of 20kl, expandable to an additional 20kl, and a sterile fill-finish capacity of one million vials a day.
The company’s platform services include process development and intensified biomanufacturing, achieving industry-leading titers. Syngene’s expertise spans a wide range of biologics, including monoclonal antibodies, recombinant proteins, mRNA, and Live Biotherapeutic Products (LBP) for the microbiome.
Attendees are encouraged to visit Booth #402 to discover how Syngene, a leading global contract research organisation, can accelerate their R&D programmes across biologics. To secure a meeting slot, interested parties can email bdc@syngeneintl.com.